Biobot
Biobot Analytics is a wastewater epidemiology company that operates a wastewater intelligence platform, analyzing sewage samples to detect and track more than 50 human health indicators — including pathogens (SARS-CoV-2, influenza, RSV, measles, norovirus), substances (fentanyl, cocaine, methamphetamine, buprenorphine), and public-health threats (HIV, mpox, poliovirus, Candida auris) — before they surface in conventional reporting. Founded from MIT research and headquartered in Cambridge, Massachusetts, Biobot serves federal, state, and local government agencies, pharmaceutical and life-sciences companies, and healthcare systems through dashboards, CSV exports, map visualizations, and enterprise data integrations. Biobot does not publish a public self-serve developer API; data access is arranged directly with the company.
Biobot is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Wastewater, Epidemiology, and Public Health.
Biobot’s developer surface includes signup flow, support, engineering blog, and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API